alexa

GET THE APP

Formulation of the Tazarotene Cutaneous Gel and Its Physicochemical Characteristics | OMICS International| Abstract
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • Clin Pharmacol Biopharm 2020, Vol 9(2): 194
  • DOI: 10.4172/2167-065X.1000194

Formulation of the Tazarotene Cutaneous Gel and Its Physicochemical Characteristics

Talieh Taheri*, Sayed Alireza Mortazavi and Alireza Dabir Siaghi
Department of Pharmaceutical Sciences, Islamic Azad University, Tehran, Iran
*Corresponding Author : Talieh Taheri, Department of Pharmaceutical Sciences, Islamic Azad University, Tehran, Iran, Tel: +989305114451, Email: [email protected]

Received Date: Mar 17, 2020 / Accepted Date: May 20, 2020 / Published Date: May 27, 2020

Abstract

Treatment of psoriasis is divided to three main types: moderate treatment (moisturizers, phototherapy and etc.), low treatment (changing the life style) and high treatment include systemic medications.

Tazaroten is one of the most effective and the most applicable dermal medicine in treatment of two mentioned diseases that available in form of gel, cream and foam. This agent is one component of vitamin A derivatives and it is a selective receptor of acetylene retinoid that binds to beta and gamma retinoid acid receptors.

The purpose of this study is formulation of cutaneous gel of Tazarotene 0.1% that is not available in the internal market of medication in Iran.

So, first the basics of medicine prepared after changing in several stages of amounts and proportions of primary materials and the effective agent added to better formulation after related stability tests. Then the stability of the formula evaluated in terms of clarity, pH, lack of two phases in temperature of 4°C, 25°C and 40°C as well as viscosity, and the best formulation was selected in terms of stability. Then the tests of determination of the effective material amount in wavelength 351 nm was performed by method of spectrophotometer and HPLC, release of medicine in plasmatic membrane and dermal absorption in the medium of acetate ammonium buffer with pH=6.5 and 10% acetonitrile on the final formulation.

The final formulation contained 85% effective material that was in the optimal range in terms of releasing and dermal absorption, while adhere to Higouchi kinetics model.

Keywords: Tazaroten; Gel; Releasing; Formulation

Citation: Taheri T, Mortazavi SA, Siaghi AD (2020) Formulation of the Tazarotene Cutaneous Gel and Its Physicochemical Characteristics. Clin Pharmacol Biopharm 9: 194. Doi: 10.4172/2167-065X.1000194

Copyright: © 2020 Taheri T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top